Dahl Inger Marie S, Rasmussen Thomas, Kauric Goran, Husebekk Anne
Section of Haematology, University Hospital, Tromsø, Norway.
Br J Haematol. 2002 Feb;116(2):273-7. doi: 10.1046/j.1365-2141.2002.03258.x.
We report on the different expression of CD56 and CD44 in plasma cells (PCs) simultaneously collected from bone marrow, extramedullary locations and peripheral blood in seven patients with multiple myeloma. Extramedullary PCs showed absence of CD56. In the bone marrow, however, subsets with varying CD56 expression were found in five out of seven patients, with one subset corresponding to that of extramedullar PCs. This differs from the de novo downregulation of CD56 in PC leukaemia, and suggests different mechanisms of spread of myeloma cells. CD44 expression was generally upregulated on extramedullary PCs. In three of the patients we investigated the clonal origin of extramedullary myeloma cells by sequencing the variable portion of the heavy chain immunoglobulin gene in phenotypically defined PCs isolated from different locations. In each patient we found malignant PCs with different homing behaviour originating from a common precursor cell.
我们报告了7例多发性骨髓瘤患者骨髓、髓外部位和外周血中同时采集的浆细胞(PCs)中CD56和CD44的不同表达情况。髓外PCs显示CD56缺失。然而,在骨髓中,7例患者中有5例发现了CD56表达各异的亚群,其中一个亚群与髓外PCs的亚群相对应。这与PC白血病中CD56的从头下调不同,提示骨髓瘤细胞的扩散机制不同。CD44表达在外周髓外PCs上通常上调。在3例患者中,我们通过对从不同部位分离的表型定义的PCs中的重链免疫球蛋白基因可变区进行测序,研究了髓外骨髓瘤细胞的克隆起源。在每例患者中,我们都发现了源自共同前体细胞的具有不同归巢行为的恶性PCs。